Emerging role of geminin as a prognostic marker in systemic malignancies

Journal of Breast Cancer

Volumn 15, Issue 4, 2012, Pages 481-

  Kapoor, Shailendra ^a  

^a Mechanicsville Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GEMININ; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 7;

ACINAR CELL CARCINOMA; ASTROCYTOMA; CANCER PROGNOSIS; CARCINOGENESIS; COLORECTAL CARCINOMA; DYSPLASIA; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; STOMACH CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 84872303814     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2012.15.4.481     Document Type: Letter

References (9)

1. Di Bonito M, Cantile M, Collina F, Scognamiglio G, Cerrone M, La Mantia E, et al. Overexpression of cell cycle progression inhibitor geminin is associated with tumor stem-like phenotype of triple-negative breast cancer. J Breast Cancer 2012;15:162-71.
2. Yamazaki M, Fujii S, Murata Y, Hayashi R, Ochiai A. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas. Histopathology 2010;56:883-92.
3. Tamura T, Shomori K, Haruki T, Nosaka K, Hamamoto Y, Shiomi T, et al. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study. J Oral Pathol Med 2010;39:328-34.
4. Shomori K, Nishihara K, Tamura T, Tatebe S, Horie Y, Nosaka K, et al. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance. Gastric Cancer 2010;13:177-85.
5. Nishihara K, Shomori K, Tamura T, Fujioka S, Ogawa T, Ito H. Immunohistochemical expression of geminin in colorectal cancer: implication of prognostic significance. Oncol Rep 2009;21:1189-95.
6. Blanchard Z, Malik R, Mullins N, Maric C, Luk H, Horio D, et al. Geminin overexpression induces mammary tumors via suppressing cytokinesis. Oncotarget 2011;2:1011-27.
7. Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 2004;204:121-30.
8. Martin CM, Astbury K, McEvoy L, O'Toole S, Sheils O, O'Leary JJ. Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy. Methods Mol Biol 2009;511:333-59.
9. Shrestha P, Saito T, Hama S, Arifin MT, Kajiwara Y, Yamasaki F, et al. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Cancer 2007;109:949-56.